The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 production

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many vaccine trials have been initiated. An important goal of vaccination is the development of neutralizing antibody (Ab) against SARS-CoV-2. However, the possible induction of antibody-dependent enhancement (ADE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Jun, Sasaki, Tadahiro, Yamanaka, Atsushi, Ichihara, Yoko, Koketsu, Ritsuko, Samune, Yoshihiro, Cruz, Pedro, Sato, Kei, Tanga, Naomi, Yoshimura, Yuka, Murakami, Ami, Yamada, Misuzu, Itoi, Kiyoe, Nakayama, Emi E., Miyazaki, Kazuo, Shioda, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660863/
https://www.ncbi.nlm.nih.gov/pubmed/34887501
http://dx.doi.org/10.1038/s41598-021-03273-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660863/
https://www.ncbi.nlm.nih.gov/pubmed/34887501
http://dx.doi.org/10.1038/s41598-021-03273-0

Ejemplares similares